ClinConnect ClinConnect Logo
Search / Trial NCT06123117

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy

Launched by HELSINKI UNIVERSITY CENTRAL HOSPITAL · Nov 5, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Laparoscopic Transversus Abdominis Plane Block

ClinConnect Summary

This clinical trial is studying two different methods of providing pain relief for patients undergoing laparoscopic cholecystectomy, a surgery to remove the gallbladder. The researchers want to compare the effectiveness of a local anesthesia technique that only numbs the small cuts made during the surgery (called trocar sites) with a newer method that combines this local anesthesia with an additional technique known as the STALL block, which targets deeper areas for better pain control. They hope that the STALL method will provide better pain relief than just using local anesthesia alone.

To participate in this study, you must be at least 18 years old and scheduled for either elective (planned) or emergency gallbladder surgery. However, if you are pregnant, have certain medical conditions, or are unable to give informed consent, you may not be eligible. If you join the trial, you can expect to receive one of the two pain relief methods during your surgery, and the results will help doctors understand the best way to manage pain after gallbladder surgery in the future. The trial is currently recruiting participants, and everyone is welcome regardless of gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients scheduled for elective or emergency LCC, aged over 18 and able to give an informed consent.
  • Exclusion Criteria:
  • Age under 18 years, chronic daily opioid and/or pain tolerance / pain threshold -modifying medication use (abuse), pregnancy, known allergy to local anesthetics, diagnosed severe coagulopathy and incapability to give informed consent for whatever reason.

About Helsinki University Central Hospital

Helsinki University Central Hospital (HUCH) is a leading academic medical institution in Finland, dedicated to advancing healthcare through innovative research and clinical excellence. As a pivotal sponsor of clinical trials, HUCH integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations between researchers, healthcare professionals, and patients. The hospital is committed to enhancing patient outcomes and contributing to the global body of medical knowledge by conducting high-quality, ethically sound clinical studies across a diverse range of therapeutic areas. With a strong emphasis on education and training, HUCH plays a vital role in shaping the next generation of healthcare leaders and researchers.

Locations

Espoo, Karvasmäentie 8, Finland

Espoo, Uusimaa, Finland

Patients applied

0 patients applied

Trial Officials

Henna Sammalkorpi, MD, PhD

Study Director

Helsinki UCH

Hanna Lampela, MD, PhD

Study Director

Helsinki UCH

Jukka Harju, MD, PhD, Doc

Study Director

Helsinki UCH

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported